-
-
-
-
-
-
-
Opus Genetics (IRD) Granted FDA RMAT Designation for OPGx-LCA5 Gene Therapy Candidate
-
-
-
-
-
-
-
Opus Genetics Announces Financial Results for Full Year 2024
-
-
-
-
-
-
-
H.C. Wainwright Assumes Opus Genetics (IRD) at Buy
-
-
-
-
-
-
1,159,341 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

